Back to search

Article

BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice

2024-06-11

Abstract excerpt

<title>Abstract</title> <p>Shigella spp. infection contributes significantly to the global disease burden, primarily affecting young children in developing countries. Currently, there are no FDA-approved vaccines against Shigella, and the prevalence of antibiotic resistance is increasing, making therapeutic options limited. Live-attenuated vaccine strains WRSs2 (S. sonnei) and WRSf2G12 (S. flexneri 2a) are highly...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
806a45c7-ec7a-5577-b5a5-3da3ab580c94
DOI
10.21203/rs.3.rs-4448907/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in miceDOI 10.21203/rs.3.rs-4448907/v1
Select a neighboring publication to make it the new centre.